Survey Data
Site Solutions Summit
An annual conference enables clinical site leaders to compare notes and share business practices.
What are appropriate turnaround times as images pass through the different stages of a clinical trial? Is the pharmaceutical industry applying outmoded thinking? Here's the context for such questions. A few weeks back, we ran an article on benchmarks in imaging. In brief, Perceptive Informatics, a division of Parexel, had adopted some standards in consultation with a nonprofit organization called the Metrics Champions Consortium. It all seemed noncontroversial. Then Jon DeVries, general manager of the eclinical business at Merge, got in touch. He competes with Perceptive and suggested, in a gentle and polite manner, that the ClinPage editorial pencil may not have been at its sharpest when that article was written. Specifically, DeVries said, the clinical trial world can ask more of imaging core labs in 2010. His view? Digital systems to move and manage images offer such big savings in time and money that the MCC benchmarks may already be…more...
With more than two decades in the industry under his belt, Jeffrey Trotter had his own contract research organization (CRO) for more than a decade. He sold it—twice. And now he's…more...
It’s easy to give a sharp salute to "quality." What modern research organization would oppose it? Quality refrigerators, quality cars, quality overnight packages can be defined easily. Quality in a clinical…more...
Investigator sites accept the need for technology like electronic data capture (EDC). But they remain puzzled about why some problematic EDC solutions are selected by clinical trial sponsor firms that seem…more...
Are international clinical trials regulated? By the FDA? By anyone? In gentle language, the U.S. Department of Human Services says that one of its own fiefdoms, the FDA, has been unable to keep up with the rapid growth in clinical research outside America. The push to find clinical trial patients outside the U.S. is not news. But…more...
This reporter is always disheartened when lawyers are ridiculed. Lately, we've been saddened by the news that a few law schools, just trying to help graduates find employment, have unilaterally granted all their students better grades. A formula here, a few computer key strokes there—and bingo! All of the lawyers just got smarter. Elastic metrics are not…more...
While it supports a cottage industry of professionals, manually pushing piles of clinical trial data along from one system to the next isn't necessarily the most efficient way of doing things. The same company may map data for the same drug in different ways in different trials—or miss errors in one trial's data set that were fixed…more...
One notable aspect of media coverage of clinical trials is the ready acceptance of the cost of a particular clinical research program. In every notable publication, as far as we can tell, the cost of a trial or a research program is confidently said to be so many tens or hundreds of millions of dollars. The amount…more...
An annual conference enables clinical site leaders to compare notes and share business practices.
Norman Goldfarb discusses recent industry trends and his upcoming conference in Boston in May.
The top CRO explains how it helps a few sites start 30 percent faster.
Michael Harte discusses a different way of working with functional service providers.
A site network discusses how it raised the level of its game.
Harvard Business Review studies an alliance between Quintiles and Solvay.
The time necessary to contract with a site isn’t any faster than three years ago.
Organizations
Conferences
Info & Opinion
© 2010 ClinPage. All Rights Reserved.